LabCorp, Quest Diagnostics Both Say 2014 Revenue Was Up

By Robert Michel | From the Volume XXII No. 5 – March 30, 2015 Issue

BOTH OF THE NATION’S LARGEST clinical laboratory companies reported increased specimen volume as a result of the Accountable Care Act (ACA), as noted in their respective fourth quarter and full-year earnings reports. First to issue its earning statement was Quest Diagnostics Incorporated. On…

Read More

---

Two Blood Brothers Report Declines in Revenue-Per-Req

By Joseph Burns | From the Volume XX No.14 – October 21, 2013 Issue

REIMBURSEMENT FOR CLINICAL laboratory testing has declined, particularly for molecular tests. As a consequence, the nation’s two largest laboratory testing companies are feeling the negative effect of lower lab test prices. Both Quest Diagnostics Incorporated and Laborator…

Read More

---

Using Accurate Data to Grow Lab Outreach

By Robert Michel | From the Volume XVIII No. 13 – September 26, 2011 Issue

CEO SUMMARY: In recent years, the laboratory outreach program at the Robert Wood Johnson University Hospital in New Brunswick, New Jersey, has achieved impressive rates of growth in specimen volume and net revenue. One reason for this success is that the lab outreach program moni…

Read More

---

Spectrum Owns MEDex, Comments on Trends

By Robert Michel | From the Volume XII No. 4 – March 7, 2005 Issue

CEO SUMMARY: Spectrum Laboratory Network recently completed its acquisition of MEDex Laboratories, Inc. of Kingsport, Tennessee. It is becoming a regional laboratory powerhouse, challenging Laboratory Corporation of America in North Carolina and establishing a sales base in Atlanta, long-…

Read More

---

Chapter 11 Bankruptcy Filed by IMPATH, Inc.

By Robert Michel | From the Volume X No. 13 – September 29, 2003 Issue

CEO SUMMARY: To the surprise of very few, IMPATH, Inc. filed for Chapter 11 bankruptcy protection. During 2003, most of IMPATH’s key executives departed as different problems within the company became known. IMPATH’s new executive leadership is dealing with a host of difficult issues….

Read More

---

20% Medicare Co-Pay A Blow to Regional Labs

By Robert Michel | From the Volume X No. 12 – September 8, 2003 Issue

CEO SUMMARY: Informed speculation indicates that private health insurers are likely to adopt some form of laboratory test co-payment if the proposed Medicare 20% lab test co-pay legislation becomes law. For hospital laboratory outreach programs, the resulting reduction of reimbursement an…

Read More

---

Are Two Blood Brothers Using Economic Clout?

By Robert Michel | From the Volume X No. 10 – July 28, 2003 Issue

CEO SUMMARY: Quest Diagnostics Incorporated and Laboratory Corporation of America now dominate the national marketplace for testing referred by physicians’ offices. Release of their second quarter earnings reports provides the first look at their performance following the acquisitions i…

Read More

---

Specialty Laboratories, IMPATH, Roche, Abbott Laboratories, Celera Diagnostics

By Robert Michel | From the Volume X No. 6 – May 5, 2003 Issue

SPECIALTY LABORATORIES RESTORING STABILITY IN SPECIMEN VOLUME IT’S NO SURPRISE THAT COMPETITORS of Specialty Laboratories, Inc. have been willing to spread a variety of rumors about the laboratory company, given its well-publicized troubles with government regulators last …

Read More

---

Quest Ready to Move on Unilab, Announces Its 2002 Earnings

By Robert Michel | From the Volume X No. 2 – February 10, 2003 Issue

PERSISTENCE IS ABOUT TO PAY OFF for Quest Diagnostics Incorporated. After ten months of effort, it expects to finalize its acquisition of Unilab Corporation within weeks. But the Unilab acquisition soon to close looks different than the acquisition that was original…

Read More

---

Business Buzz Saw Hits Anatomic Path Firms

By Robert Michel | From the Volume IX No. 8 – June 3, 2002 Issue

CEO SUMMARY: In recent years, both companies have enjoyed sustained and rapid growth in offering anatomic pathology (AP) services nationally. The departure of CFOs from both companies, each for different reasons, is a sign that such unbridled growth has created unique problems for each AP…

Read More

---